Bonesupport Holding AB

BONEX · Nasdaq Stockholm · Healthcare

222.60SEK −1.5%last day

Price as of 2 October 2026

The price over the past year, with dividends: −23.7%

Performance

1 month

−2.3%

1 year

−23.7%

3 years, per year

+21.2%

5 years, per year

+41.4%

Largest fall, 3 years

−58.0%

Below the peak now

−44.4%

Volatility, 1 year

49.7%

Return with dividends reinvested.

Key figures

P/E

67.1

P/B

15.1

Dividend yield

0.0%

Return on equity

+22.5%

Net margin

+16.6%

Market value

1.5 bn USD

Quality, value and trend

Where Bonesupport Holding stands against every Nordic stock today. 100 is best.

Quality99

Profitability and a sound balance sheet over time. Better than 99% of Nordic stocks.

Value8

The price measured against earnings, assets and cash flow. Better than 8% of Nordic stocks.

Trend38

The price development over the past year. Better than 38% of Nordic stocks.

Combined43

Quality, value and trend together. Better than 43% of Nordic stocks.

About Bonesupport Holding

Bonesupport Holding AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 170 employees.

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone…

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis